Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

May 08 • 04:00PM ET

9.35

+0.05 0.54 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CABA RNAC CRBU FATE SANA

| Held by: VTI VXF IBB SCHA DWAS SURI IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.66	Insider Own	39.77%	Shs Outstand	60.39M	Perf Week	5.41%
Market Cap	565.96M	Forward P/E	-	EPS next Y	-2.98	Insider Trans	1.02%	Shs Float	37.53M	Perf Month	-2.40%
Enterprise Value	315.74M	PEG	-	EPS next Q	-0.75	Inst Own	42.42%	Short Float	11.28%	Perf Quarter	17.91%
Income	-161.31M	P/S	-	EPS this Y	16.12%	Inst Trans	21.40%	Short Ratio	5.12	Perf Half Y	34.53%
Sales	0.00M	P/B	2.43	EPS next Y	2.51%	ROA	-53.64%	Short Interest	4.23M	Perf YTD	-0.53%
Book/sh	3.85	P/C	2.03	EPS next 5Y	12.50%	ROE	-64.67%	52W High	13.67 -31.60%	Perf Year	338.97%
Cash/sh	4.61	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-62.68%	52W Low	1.96 377.04%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.21% 8.61%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-5.71%	Oper. Margin	-	ATR (14)	0.69	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.82	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.75	EPS Q/Q	7.59%	SMA20	0.00%	Beta	2.06	Target Price	29.60
Payout	-	Debt/Eq	0.12	Sales Q/Q	-	SMA50	5.46%	Rel Volume	0.56	Prev Close	9.30
Employees	130	LT Debt/Eq	0.11	Earnings	Mar 26 AMC	SMA200	30.51%	Avg Volume	826.40K	Price	9.35
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% -	Trades		Volume	458,951	Change	0.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)